How do you choose which BTK inhibitor to use in NHL?
Does the safety profile impact your choice significantly?
Does your first choice vary by disease histology?
1 Answer
Mednet Member
Hematology · University of California Irvine
Answered on
At this point, I use very little ibrutinib. If I need CNS penetration, ibrutinib has a track record there. Otherwise, I have pivoted to acalabrutinib and zanubrutinib. I typically will pick by indication - acala for CLL and zanu for WM/MZL. In MCL or likely soon in CLL, I am not entirely sure how to...
Join for free or sign in to see the full answer